Molecular Magnetic Resonance Imaging of Dysregulated Zinc Secretion Detects Early Pancreatic Ductal Adenocarcinoma Lesions and Response to KRASG12D Inhibitor Treatment
Jordan, V. C.; Sojoodi, M.; Moloudi, F.; Pagan, P. G.; Jin, M.; Pantazopoulos, P.; French, E.; Weigand-Whittier, J.; Rotile, N.; Tavallai, M.; Hallin, J.; Ramsay, I.; Gale, E. M.; Barrett, S.; Bardeesy, N.; Qadan, M.; Tanabe, K.; Caravan, P.
Show abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, primarily due to late-stage diagnosis and limited treatment options. Zinc homeostasis is markedly dysregulated in PDAC and this dysregulation can be probed by administering a secretagogue to stimulate zinc secretion (SSZS) in the exocrine pancreas and imaging this secretion with a zinc sensitive MRI probe. This study demonstrates the potential of SSZS MRI for early detection, monitoring treatment response, and assessing recurrence after treatment withdrawal in PDAC. Our approach relies on interrogating the pancreas, circumventing the challenge of locating small, elusive tumors. By SSZS MRI, we detected PDAC by observing the unique zinc hypersecretory activity of the pancreas when malignancy is present. We observed dysregulation of zinc transporters in both human and mouse pancreas containing PDAC and confirmed secretagogue-stimulated zinc secretion in vitro and in vivo. We found that combining secretagogues such as secretin and caerulein maximized zinc secretion and as such MRI signal in the pancreas. Notably, SSZS MRI detected treatment responses to KRAS G12D inhibition within 3-5 days and identified cancer recurrence as early as one day post-treatment withdrawal. Additionally, secretagogue stimulation improved treatment responses and delayed recurrence in both treatment models. These findings suggest that SSZS MRI could significantly enhance PDAC diagnosis and management, providing a novel, non-invasive imaging modality to improve patient outcomes. STATEMENT OF SIGNIFICANCEThis study demonstrates the utility of secretagogue-stimulated zinc secretion (SSZS) MRI in detecting pancreatic ductal adenocarcinoma (PDAC) at early stages, monitoring treatment responses, and assessing cancer recurrence, thereby offering a promising non-invasive imaging modality to improve PDAC patient management and outcomes.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 94%
- Single cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree 93%
- A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer 93%
Similar papers in this journal
- Imaging CRISPR-Edited CAR-T Cell Therapies with Optical and Positron Emission Tomography Reporters 92%
- Focused ultrasound ablation of melanoma with boiling histotripsy yields abscopal tumor control and antigen-dependent dendritic cell activation 91%
- The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities 91%
Similar papers in this journal
- Rapamycin Immunomodulation Utilizes Time-Dependent Alterations of Lymph Node Architecture, Leukocyte Trafficking, and Gut Microbiome 92%
- Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma 92%
- Ddr1-Induced Neutrophil Extracellular Traps Drive Pancreatic Cancer Metastasis 92%
Similar papers in this journal
- In vivo imaging of individual islets across the mouse pancreas reveals a heterogeneous insulin secretion response to glucose 93%
- Optogenetic Stimulation of Pancreatic Function via Vagal Cholinergic Axons 92%
- Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic 91%
Similar papers in this journal
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition 93%
- Ductal pancreatic cancer interception by FGFR2 abrogation 92%
- Hypoxia driven oncometabolite L-2HG maintains "stemness"-differentiation balance and facilitates immune suppression in pancreatic cancer 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.